U.S. Capital Markets – Financial Tools of Choice for the Life Sciences Industry

A joint initiative of Greenberg Traurig, BNY Mellon and HCW, GT's Tel Aviv Office will be hosting a morning roundtable for life sciences companies interested in learning about the different financial tools available in U.S. capital markets.

Israel Practice Co-Chair Bob Grossman and Shareholder Joshua Samek, both active members of the firm's corporate and securities practice, will be in attendance. Both Bob and Josh have a strong focus on the life sciences industry in general, and the Israeli one in particular.